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Abstract 
Background 
Most industrialized countries are faced with a growing population of patients with chronic 
diseases and multimorbidity. Evidence performance gaps have been recognized in the treatment 
of this vulnerable patient group. In England, the Quality and Outcomes Framework (QOF) – 
based on incentivized quality indicators – has been established to narrow the gap.  
 
Objective 
We evaluated to what extent clinical data, extracted from electronic medical records (EMRs) of 
Swiss general practitioners, can be used as quality indicators in terms of a Swiss Quality and 
Outcomes Framework (SQOF) for diabetes care adopted from the QOF of the United Kingdom 
National Health Service (NHS). 
 
Methods 
We searched the FIRE database (Family medicine ICPC-Research using Electronic medical 
records) for patients suffering from diabetes type 1 or type 2. Eligible data were matched with the 
diabetes indicator set of the NHS QOF and compared with the results in England. 
 
Results 
Eleven out of 17 diabetes indicators could be adopted for the SQOF. 46 practices with 1,781 
diabetes patients were included. The practices fulfilled the SQOF diabetes indicator set overall 
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with 46.9% with highest compliance for blood pressure measurements (97.8% of all practices), 
lowest compliance for influenza immunization (45.7%). 
Our study practices showed higher variation across all indicators and between practices compared 
to England but lacking structured data limited calculation of scores and comparability. 
 
Conclusions 
Our results show that it is technically feasible to establish a diabetes QOF in Swiss primary care 
based on EMRs. However, a high amount of missing data made it impossible to evaluate the 
actual quality of care. For a nationwide introduction standards for electronic medical 
documentation and EMR use need to be set. It should also be acknowledged that important 
dimensions of suffering from one or more chronic diseases such as health related quality of life 
are not reflected within a system focusing only on somatic aspects of a disease. 
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Introduction 
Background 
Chronic diseases and multimorbidity present the most common disease pattern and have 
significant medical and economic implications. As in many other modern industrial countries, the 
growing prevalence of chronic diseases such as diabetes challenges the healthcare financing 
system in Switzerland (1-6). Since large diabetes studies provided evidence that the achievement 
of certain target values (e.g. for HbA1c and blood pressure) influences the long term outcome of 
patients with diabetes, many treatment guidelines and recommendations for disease management 
have been published, with the intention of improving the quality of care and subsequently 
minimizing the long term effects of disease and reducing healthcare costs (7-11). However, in 
Switzerland currently exists no monitoring system that documents the adherence of healthcare 
providers to the evidence based standards of diabetes care or rather their related clinical outcomes 
and influences on health related quality of life (HRQL). Today, the responsibility for ongoing 
management of patients with diabetes rests primarily with general practitioners and the primary 
care team, who are traditionally working in single handed private practices with a fee-for-service 
payment. Therefore, it is neither possible to assess the true epidemiology of diabetes and the 
current level of treatment outcomes in general, nor is it possible to systematically evaluate the 
impact of new disease management programs and other changes in healthcare delivery such as 
the introduction of integrated care programs. Indeed, due to observations from previous studies, a 
large evidence-performance-gap must be supposed (12; 13). 
On the contrary, other nations successfully implemented measurement systems allowing 
monitoring of health care quality and the achievement of treatment targets. In 2004 the United 
Kingdom National Health Service (NHS) introduced the Quality and Outcomes Framework 
(QOF), a voluntary annual reward and incentive programme for all general medical practices in 
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England, Wales, Scotland and Northern Ireland and part of the General Medical Services (GMS) 
contract for general practices. (14). The intention of this initiative is to encourage appropriate and 
high quality clinical care for key long-term conditions by detailing and displaying the overall 
practice achievement through a points system. At the end of the financial year the total number of 
practice achievement points is converted into a payment amount, which can be seen as a reward 
for adherence to evidence based care and implementing «good practice». In this context, the NHS 
QOF provides a range of clinical quality indicators, based on the best available evidence, against 
which practices score points according to their level of achievement in the care of different high 
prevalent diseases such as diabetes (14-16). 
 
Aim of the study  
The main objective of this study was to investigate to what extend clinical data, extracted from 
electronic medical records (EMRs) of Swiss general practitioners (GPs), can be used as diabetes 
quality indicators in terms of a Swiss Quality and Outcomes Framework (SQOF) adopted from 
the NHS QOF. In absence of an overall Swiss monitoring system collecting relevant EMR data 
needed to calculate the scoring of individual general medical practices, we reverted to the FIRE 
database (Family medicine ICPC-Research using Electronic medical records), a standardized 
collection of clinical routine data extracted from EMRs of Swiss GPs (17).  
In a first step, we investigated to what extend clinical routine data based on the EMRs contain the 
information that is needed to apply the NHS QOF indicator set for diabetes care. Applicable 
indicators were adopted and were used to construct the SQOF. In a second step we measured the 
achievements of Swiss GPs against these quality indicators and compared the results with the 
average results of GPs in England, available online at the NHS Information Centre for Health and 
Social Care (18). 
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Methods  
The Quality and Outcomes Framework of the United Kingdom National Health Service has 
undergone several revisions since its introduction in 2004, the latest changes were made in April 
2012 (19). We based our analyses on the QOF «Online GP practice results database» of the year 
2010/11 as the latest evaluated year available online (20). 
We listed the NHS QOF diabetes indicator set and reviewed to what extent these indicators were 
mirrored in clinical routine data extracted from the FIRE database. The FIRE database is the 
centrepiece of an ongoing research project at the Institute of General Practice and Health Services 
Research of the University of Zurich, Switzerland, started in 2009. Its establishment and data 
structure are reported elsewhere (17). In brief, the database contents structured medical data that 
GPs routinely assess during patient encounters and enter in their EMR software. GPs extract 
these data from their EMR software monthly by the means of an Extensible Markup Language 
(xml) export tool currently provided by the five leading EMR software companies of the Swiss 
Market. Participation in the project is voluntarily and not incentivized, participants are recruited 
consecutively. 
The NHS QOF diabetes indicators are based on patient data collected within 15 months since the 
last annual NHS QOF evaluation. Therefore, we focussed our analysis on data extracted from the 
FIRE database with respect of at least 15 months of treatment. Eligible extracted data from the 
EMRs were adopted and built the Swiss Quality and Outcomes Framework. We measured the 
achievements of FIRE practices against the SQOF diabetes indicators. Both the overall 
achievement of FIRE practices and the achievement of each single practice were statistically 
evaluated. Subsequently the SQOF data were compared with the average results of the general 
medical practices in England. To accomplish this task we used the QOF 2010/11 practice level 
data tables and the QOF 2010/11 prevalence data tables respectively, both available online at the 
NHS Information Centre for Health and Social Care (16).  
6 
Djalali, et al. Gerontology 2014; DOI: 10.1159/000357370 
Furthermore, we calculated if FIRE practices would have gained an achievement reward 
according to the NHS QOF reimbursement policy by applying the NHS QOF calculation of 
points of the diabetes indicator set (21). The applicable NHS QOF diabetes indicators have 
designated achievement thresholds also called payment stages. If a practice has achieved a 
percentage score in relation to a particular indicator that is the minimum set for that indicator (or 
below) it achieves no points. If a practice has achieved a percentage score that is between the 
minimum and the maximum set for that indicator, it achieves a proportion of the points which is 
rewarded with a certain amount (21). We also calculated the mean points achieved per NHS QOF 
practice by using the QOF 2010/11 practice level data tables and compared those outcomes with 
the outcome of FIRE practices (16). 
 
Data extraction from FIRE database 
Consultation data recorded in the FIRE database between January 2009 and June 2012 were used 
for the study. These data included 776,679 consultations derived from 136,132 patients and 
937,858 medical problems according to the ICPC-2 classification (International Classification of 
Primary Care 2) (22). The FIRE data further cover patient demographics, vital signs, laboratory 
data and type and dosage of prescribed medication at the level of individual consultations. 
Prescription drugs are classified according to Anatomical Therapeutic Chemical/Defined Daily 
Dose Classification ATC/DDD coding established by the WHO (23).  
Case histories of patients in the database were established by sorting individual physician-patient 
encounters by patient and date.  
Inclusion criteria were: patients with type 1 or type 2 diabetes and a case history of at least two 
encounters with an interval of at least 15 month. Patients with diabetes type 1 or type 2 were 
7 
Djalali, et al. Gerontology 2014; DOI: 10.1159/000357370 
identified either by ICPC-2 codes or by type of prescribed medication classified according to 
ATC/DDD within their case history.  
Comorbid conditions were determined by calculating the average number of conditions per 
patient, identified either by ICPC-2 codes or by type of prescribed medication. A set of specific 
ICPC-2 codes was applied to define chronicity from a diagnostic perspective (24) and the concept 
of pharmaceutical cost groups (PCGs) to define chronicity from a therapeutic perspective (25).  
 
Results 
Study population characteristics 
A total of 4,832 patients with diabetes type 1 or type 2 derived from 136,132 patients were 
extracted from the FIRE database in June 2012. 3,148 patients were identified by type of 
prescribed medication classified according to ATC/DDD coding, 537 patients were identified by 
respective ICPC-2 codes and 1,147 patients by both coding schemes. The average age of all 
patients with diabetes was 67.7 years, 69.8 years for the 2,097 female patients and 66.1 years for 
the 2,735 male patients. The average number of comorbid conditions per patient was 1.6 for 
ICPC-2 codes and 1.3 for PCGs.  
Of all patients with diabetes 1,781 had clinical data measurements covering at least 15 months of 
treatment and thus fulfilled the inclusion criteria. Thereof 1,038 patients were identified by 
ATC/DDD coding, 190 by ICPC-2 codes and 553 by both coding schemes. The mean age was 
69.3 years. 779 patients were female with an average age of 71.3 years and 1,002 were male with 
an average age of 67.7 years. On average 14 consultations per patient were documented within 
the previous 15 months of treatment. The average number of comorbid conditions at patient level 
was 2.6 for ICPC-2 codes and 3.7 for PCGs. Comorbid conditions could be assigned to all ICPC-
2 chapters, except chapter W and Z (W, pregnancy, family planning; Z, social). The most 
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frequent chapters were K, L and T (K, circulatory; L, musculoskeletal; T, metabolic, endocrine, 
nutritional) (suppl. table 1). The three most frequent comorbid conditions according to PCGs 
were hypertension, coronary and peripheral vascular disease and hyperlipidaemia with 17.8%, 
15.1% and 12.4% respectively. Cardiac disease was stated in 6.6% and renal disease in one 
patient (0.02%). 
 
Application of NHS QOF indicators  
The QOF diabetes indicators for the year 2010/11 published by the United Kingdom National 
Health Service consist of a set of seventeen indicators against which practices score points 
according to their level of achievement (15; 26). On this basis, we focused on eleven indicators 
which we were able to extract from the FIRE database and thus defined eleven Swiss Quality and 
Outcomes Framework diabetes indicators as shown in table 1. Considering the SQOF indicator 
number eleven in comparison with the corresponding NHS QOF indicator, the FIRE database 
only provides records of serum creatinine testing and not of estimated glomerular filtration rate 
(eGFR). Thus, we adapted the SQOF indicator accordingly. Further, we did not include the NHS 
QOF indicator stating if a practice can produce a register of all patients aged 17 years and over 
with diabetes by specifying diabetes type 1 or type 2, since the FIRE database itself represents a 
register from which such data can be extracted. The following NHS QOF diabetes indicators 
were not applicable to the FIRE database and therefore excluded from the analysis: (a) 
percentage of patients with diabetes with a record of the presence or absence of peripheral pulses 
in the previous 15 months, (b) percentage of patients with diabetes with a record of neuropathy 
testing in the previous 15 months, (c) percentage of patients with diabetes who have a record of 
micro-albuminuria testing in the previous 15 months (exception reporting for patients with 
proteinuria), (d) percentage of patients with diabetes with proteinuria or micro-albuminuria who 
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are treated with ACE inhibitors (or A2 antagonists) and (e) the percentage of patients with 
diabetes who have a record of retinal screening in the previous 15 months.  
 
SQOF diabetes indicators 
The first SQOF indicator assesses the proportion of patients with diabetes whose notes record a 
Body Mass Index (BMI) in the previous 15 months since last consultation (table 1). Of the 1,781 
patients in our study 747 (41.9%) had respective measurements with one record on average (min. 
0, max. 28). 258 patients (14.5%) had at least one BMI entry in their case history, however not 
within the preceding 15 months and 776 patients (43.6%) had no BMI measured at all. Of the 747 
patients with a BMI measurement 7.8% had a BMI of <25 kg/m2, 32.0% had a BMI of 25-35 
kg/m2 and 10.3% had a BMI of >35 kg/m2. 
The quality indicators number two to five include the percentage of patients with diabetes with a 
record of HbA1c in the previous 15 months since last consultation and the degrees of attainment 
of defined target values (suppl. table 2). Of the 1,781 patients with diabetes with at least 15 
months of treatment 1,346 (75.6%) had an HbA1c record during the respective period of time, 
188 (10.6%) had at least one HbA1c record, though not within the preceding 15 months since last 
consultation and 247 (13.9%) had no HbA1c measured at all. HbA1c was measured 2.4 times 
(min. 0, max. 13) on average per patient. The proportion with recorded last HbA1c of ≤7% was 
41.4% and 34.1% with recorded last HbA1c of >7%. We assessed 62.1% of patients in whom the 
last HbA1c was ≤8% and 13.5% with an HbA1c of >8%. The percentage with recorded last 
HbA1c of ≤9% was 70.3% and 5.3% with a last HbA1c of >9%. Related to the 1,346 patients 
with an HbA1c record 54.8% had a last HbA1c of ≤7% and 45.2% had a last HbA1c of >7%. 
Considering a last HbA1c of ≤8% and of >8%, 82.2% were below and 17.8% above the 
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threshold. The proportion of the 1,346 patients for recorded last HbA1c of ≤9% was 93% and 7% 
for last HbA1c of >9%.  
The quality indicators number six and seven quantify the blood pressure measurement and the 
defined target value. 1,460 patients (82%) of the study population had a measurement of blood 
pressure in the previous 15 months since last consultation, with an average of 4 records (min. 0, 
max. 47). 316 patients (17.7%) had at least one blood pressure entry in their case history, but not 
within the preceding 15 months and five patients (0.3%) had no blood pressure measurement at 
all. The percentage of patients with diabetes in whom the last blood pressure was ≤145/85 mmHg 
corresponds to 48.8% and to 33.2% for a last blood pressure measurement of >145/85 mmHg. Of 
the 1,460 patients with a measurement of blood pressure 59.5% had a last blood pressure of 
≤145/85 mmHg and 40.5% one of >145/85 mmHg.  
The quality indicators number eight and nine include the total cholesterol measurement and the 
defined total cholesterol target value. Of the 1,781 patients with diabetes covering at least 15 
months of treatment 662 (37.2%) had a record of total cholesterol in the previous 15 months since 
last consultation, 198 (11.1%) had at least one total cholesterol record, however not during the 
respective time period and 921 (51.7%) had no such record at all. On average total cholesterol 
was recorded 0.5 times (min. 0, max. 20) per patient. 22% of the study population had a last 
measured total cholesterol of ≤5 mmol/l and 15.2% one of >5 mmol/l. In relation to the 662 
patients with total cholesterol record 59.2% of them had a last measured total cholesterol of ≤5 
mmol/l and 40.9% one of >5 mmol/l. 
The quality indicator number ten assesses the proportion of patients with diabetes who have had 
influenza immunization (ATC code J07BB) in the preceding period from 1st September to 31st 
March within the previous 15 months since last consultation and corresponds to 278 patients 
(15.6%). 
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The last quality indicator includes the serum creatinine testing with an average of one record 
(min. 0, max. 19) at patient level. Of the 1,781 patients in our study 878 (49.3%) had a record of 
serum creatinine testing in the respective time period since last consultation, 200 (11.2%) had at 
least one serum creatinine testing, though not within the previous 15 months since last 
consultation and 703 (39.5%) had no such testing at all. 
 
SQOF diabetes indicators at practice level 
46 Swiss general medical practices participating as of June 2012 in the FIRE project showed 
EMRs for patients with diabetes with the respective clinical data within a timeline of at least 15 
months of treatment. On average 39 patients per practice were recorded (min. 1, max. 110). A 
crosscheck against the original FIRE database showed that all practices had recorded the required 
clinical data at least once in patients other than the included patients with diabetes.  
The 46 practices fulfilled the SQOF diabetes indicator set overall with 46.9% (min. 0.0%, max. 
75.4%). The rate of practices fulfilling the respective SQOF diabetes indicators is depicted in 
table 1. Highest compliance was reached for blood pressure measurements (indicators six and 
seven; 97.8% and 95.7% of practices) and HbA1c measurements (indicators two, four and five; 
95.7% each), lowest compliance for influenza immunization (indicator ten; 45.7% of practices). 
Further, for the mean percentage of patients in whom the respective SQOF diabetes indicators 
had been fulfilled by practice, highest compliance was achieved in indicator six with 77.2% 
average (min. 0.0%, max. 100%), stating a record of the blood pressure in the previous 15 months 
since last consultation and indicator two, stating an HbA1c measurement in that period (72.5% 
average, min. 0.0%, max. 100%). Lowest compliance was achieved in indicator ten with 12.8% 
average (min. 0.0%, max. 76.2%).  
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In general, for each indicator a minimum of 0% can be reported and the maximum varies from 
76.2% to 100% across the indicators. The minimum values can be traced back to 33 different 
practices which produced at least one value of 0.0%. Suppl. table 3 provides information about 
the amount of practices which produced the minimum values by systematically lacking records in 
relation to specific indicators.  
 
 
 
Comparison of Swiss QOF with NHS QOF 
Suppl. figure 1 provides an overview of the achievements of GPs in Switzerland compared to 
those in England and shows the mean percentages of patients in whom the respective SQOF and 
NHS QOF diabetes indicators have been fulfilled by practice. 
Of the general medical practices participating in the FIRE project, 46 practices were keeping 
records of 1,781 patients with diabetes within at least 15 months of treatment, on average per 
practice 39 patients (min. 1, max. 110) were counted. In England for the evaluated year 2010/11, 
8,245 general medical practices were included in the published results covering almost 100% of 
registered patients with an average of 298 patients per practice (min. 0, max. 1,835). In general, 
the SQOF compliance is lower than the NHS QOF compliance. The 46 Swiss GP practices 
fulfilled the SQOF diabetes indicator set overall with 46.9% (min. 0.0%, max. 75.4%). The 8,245 
general medical practices in England fulfilled the applicable NHS QOF diabetes indicators 
overall with 87.2% (min. 0.0%, max. 100.0%). Variations between practices in both countries are 
shown in suppl. figure 2. 
The lowest value is reported for SQOF indicator ten (influenza immunization) with 15.6% of the 
study population and 12.8% of patients’ average at practice level compared with a NHS QOF 
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patients’ average of 91.2% per practice. Indicator six (blood pressure control) showed the highest 
SQOF value with 82.0% of the study population and 77.2% of patients per practice. In England, 
likewise, highest compliance was shown in indicator six, reaching a patients’ average of 98.4% at 
practice level. Patients with diabetes within the NHS QOF achieved a target blood pressure of 
≤145/85 mmHg with averaged 81.4% of patients per practice compared with 46.7% of patients 
on average per FIRE practice and with 48.8% of the study population. The lowest compliance 
within NHS QOF is shown for recorded last HbA1c of ≤7% (indicator three) with averaged 
54.4% of patients at practice level compared with averaged 39.5% of patients per FIRE practice 
and with 41.4% of the study population. In England, HbA1c check (indicator two) was carried 
out with 97.3% patients’ average per practice compared with 72.5% patients’ average per FIRE 
practice and with 75.6% of the study population.  
The mean difference between practice achievements in Switzerland and England across all 
indicators was 40.2%. 
 
Practice achievements reward 
Table 2 shows the percentage of Swiss general medical practices achieving points in relation to a 
particular SQOF indicator and the average points achieved per practice in comparison with the 
average points achieved by GP practices in England.  
On average, Swiss GP practices gained a proportional achievement reward for 6.4 (min. 0, max. 
11) out of 11 indicators and scored maximum points for 2.0 (min. 0, max. 7) indicators. Highest 
compliance rate was reached for indicator six (blood pressure control) with 93.5% of all practices 
gaining an average of 2.2 points of 3 points available. Lowest compliance rate is reported for 
indicator ten (influenza immunization) with 15.2% of all practices gaining an average of 0.2 
points of 3 points available. Maximum points were scored most frequently (41.3% of all 
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practices) for indicator four (HbA1c of ≤8%) and most rarely (0.0% of all practices) for indicator 
ten. The variation is depicted in suppl. figure 3. 
In England, GPs gained a proportional achievement reward for 10.9 (min. 0, max. 11) out of 11 
indicators and scored maximum points for 5.7 (min. 0, max. 6) indicators on average. 
Compliance rates varied across indicators between 99.7% and 99.9% of all practices. For most 
indicators over 90% of all practices scored maximum points, except for indicators three, four and 
five. The lowest rate was found in indicator three (HbA1c of ≤7%) with only 0.2% of all 
practices achieving maximum points (suppl. fig. 3). 
 
Discussion 
Swiss health care is characterized by an almost complete lack of monitoring and evaluation of 
medical practice at the health system level and primary care is no exception in this context. 
Within a pilot study we evaluated to what extent it is feasible to implement a Quality and 
Outcomes Framework to reflect the current quality of diabetes care in Swiss primary care 
practices. We used the internationally well accepted QOF diabetes indicators of the United 
Kingdom National Health Service (NHS) as the methodological basis of our framework. The data 
were obtained from Swiss general medical practices participating in the FIRE project. This 
project pools clinical routine data for research and quality improvement in Swiss primary care. 
Participants import standardized structured clinical routine data from their EMR software to a 
database. We investigated whether clinical routine data extracted from EMRs provide valid 
quality indicators of diabetes care with reference to quality indicators defined by the NHS QOF.  
Eleven out of seventeen NHS indicators could be adopted and built the Swiss Quality and 
Outcomes Frameworks. Comparing the practice achievements of Swiss GPs to achievements of 
GPs participating in the NHS QOF in England, great discrepancies of 40.2% average were found 
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across all indicators. For example, in indicator three (HbA1c of ≤7%), Swiss practices gained a 
mean point score of 7.4, which is lower than the mean score in England (14.7). On the other 
hand, only 0.2% of all English practices achieved maximum points for this indicator compared to 
37% of the Swiss practices. Generally, GP practices in England showed a high and stable 
performance across all indicators with compliance rates close to 100%, whereas Swiss practices 
showed high variance between the indicators and between practices. XXX 
Our results show that Swiss EMR software products are currently lacking structured data 
elements in order to implement all seventeen diabetes indicators of the NHS QOF. Software 
products for EMR currently available in Switzerland do not provide specific fields and check 
boxes that would allow structured entry of specific clinical findings and laboratory results related 
to certain diabetes related exams. Users have to rely on «work-arounds» and document clinically 
important outcomes in the form of free text notes or scan paper documents into the EMR as PDF 
files. Both free text notes and PDF files are not searchable electronically and such information 
cannot be exported and is thus not available for subsequent statistical analysis. Indicators of both 
process and outcome quality of care are therefore difficult to establish. 
In concrete terms this means that we had to drop all indicators reflecting the control of macro- 
and microvascular complications of diabetes, particularly examination of peripheral pulses, 
neuropathy testing, micro-albuminuria testing and retinal screening.  
Nevertheless, we were able to adopt eleven indicators for the evaluation of diabetes treatment, 
which reflect both relevant processes of care and outcome achievements. A crosscheck against 
the original FIRE database showed that all practices had recorded the required clinical data at 
least once in patients other than the included patients with diabetes. So, we reassured that all 
practices were technically capable of providing data for an evaluation.  
Thus, we conclude that it is technically feasible to rely on clinical routine data extractions from 
EMRs in order to establish a diabetes QOF in Swiss primary care.  
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However, technical feasibility is not the only requirement for the establishment of a Quality and 
Outcomes Framework. It must be reassured that the data provided by the practices are complete 
and truly reflect their working processes and outcome achievements.  
Within a QOF system there are two steps of data processing that might be a source of bias 
compromising the reliability of data and therefore the validity of the evaluation’s results: 1) data 
capturing with EMR software and 2) data extraction from EMR software and transmission to the 
evaluation institution. 
Our results suggest that Swiss GPs miss to or are hindered to capture complete data for all 
patients to all times with their EMR software: Despite general technical capability to extract and 
export the requested data, only 12 out of 46 practices in the FIRE project actually identified all 
eleven SQOF indicators. The high amount of missing values explains the great discrepancy 
between the practice achievements of GPs in Switzerland and England.  
The question rises, why Swiss GPs seemingly use different practices of electronic medical 
documentation than GPs in England. 
In England, the QOF is inseparable from a pay for performance reimbursement system that 
rewards participating GPs for fulfilling the quality indicators. So, GPs have an incentive to keep 
complete electronic medical records of their patients and to document every treatment process 
related to the quality indicators. Participation in the QOF program requires use of certified EMR 
software particularly supporting data extraction and transfer to the Quality Management Analysis 
System (QMAS), a national IT system developed by NHS Connecting for Health, designed to 
calculate the practice achievements and provide the QOF statistics. Under these circumstances, it 
can be supposed that missing values in the data sets provided for evaluation would mostly 
correspond to failing treatment performances.  
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In contrast to that, GPs in our study received no incentives nor were they aware of the specific 
evaluation of their data entries. In this case, it is possible that missing values are not only due to 
failing treatment performances but also due to failures in data capturing.  
Depending on the examination and the individual IT equipment of a practice, certain laboratory 
values and clinical results are recorded automatically in the EMR, whereas other values and 
results have to be typed in by the GP or the practice nurse. Automatic data input is considered to 
be reliable, so that missing data would also correspond to failing treatment performances. On the 
other hand, manual data input is considered to be less reliable and a potential source of bias.  
In order to fulfil the SQOF indicators, GPs had to undertake five different examinations within 15 
months, precisely measurements of BMI, blood pressure, HbA1c, total cholesterol and serum 
creatinine. With the existing EMR software products in Switzerland, both BMI and blood 
pressure measurement acquire manual data input by the examiner, whereas the values of HbA1c, 
total cholesterol and serum creatinine could possibly be imported automatically from a laboratory 
database or the practice’s own electronic laboratory equipment. However, interfaces connecting 
EMR software and external data sources such as laboratory databases and laboratory equipment 
are expensive and still many GPs in Switzerland refrain from implementation of such interfaces 
and rely on manual data input or file paper documents instead.  
Our analysis of individual practice achievements showed that 18 practices were systematically 
lacking records of BMI, blood pressure, HbA1c, total cholesterol and/or serum creatinine 
measurements in their patients with diabetes type 1 or 2. As the FIRE database contains no 
information about the individual IT equipment of participating practices, it remains unclear, 
whether the respective data of HbA1c, total cholesterol and serum creatinine measurements were 
imported from external data sources or entered manually. It is very likely that these practices 
document the respective laboratory results constantly elsewhere than in the designated EMR 
input field, so that the results are «invisible» for data extraction and evaluation. Similar 
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considerations apply to immunisations that are often only documented on patients’ paper based 
vaccination certificates. Still, it is also possible that these practices don’t follow the state of the 
art in diabetes care and simply don’t undertake the corresponding examinations. The different 
possibilities of data capturing also explain the great variations of achievements that were seen 
between Swiss practices. Financial rewards for complete data capturing might have motivated all 
GPs to check medical records for completeness and add information that is stored elsewhere 
before importing data to the FIRE database. Without financial incentives, it is very likely that 
many GPs use not all functions for structured data entry of their EMR software.  
In summary, it was not possible in our study to distinguish between poor indicator achievements 
due to a poor treatment performance and poor indicator achievements due to poor data input.  
Thus, we conclude that it is not appropriate to evaluate the actual quality of Swiss diabetes care 
today on the basis of clinical routine data extracted from EMRs.  
 
Strengths and Limitations 
There are several strengths and limitations in this study that need to be acknowledged. The main 
strength of the study is the use of quality indicators based on the well-established NHS QOF. The 
NHS QOF indicators are developed and tested in a multi-step and methodological process 
designed to reassure clarity, necessity, feasibility, reliability, acceptability and cost-effectiveness 
(27). Particularly the diabetes indicators and the effect of associated pay-for-performance 
schemes on the quality of diabetes care have been investigated intensively (28-31). Irrespective 
of discussions whether the introduction of financial incentives led to an improvement of the 
recorded quality of primary care for patients with diabetes, it is acknowledged that the NHS 
diabetes indicator set covers relevant processes of diabetes care. As a consequence, these 
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indicators can be seen as the general basis when investigating whether a set of clinical routine 
data extracted from EMRs is qualified for the monitoring of quality in diabetes care.  
 
Furthermore, the alignment with the NHS QOF allowed us to benchmark the results of the quality 
and outcomes assessment of the Swiss GP population against the real life results of English GPs. 
Of course, it should be acknowledged that the comparability between these two populations is 
very limited, because the groups were not randomized and analyses did not control for potential 
confounders. So, the results of our study cannot be used to compare the actual quality of diabetes 
care in Switzerland and England. However, it is feasible to derive important conclusions about 
the different practices of medical documentation and EMR use, prerequisites for the successful 
participation of GPs in a QOF system.  
In this context, it is clearly the strength of this study that the analyses are based on the substantial 
FIRE database. Until today this database is the largest collection of structured primary care 
clinical routine data in Switzerland, providing data of 776,679 consultations derived from 
136,132 patients. Given the fact that approximately 10−20% of all Swiss general practitioners 
currently keep EMRs (32), the total of consultation records represents an adequate sample. 
Therefore our results can be considered applicable to all physicians currently using EMRs in 
Swiss primary care, even though the study was restricted to data entries of 46 general 
practitioners treating patients with diabetes for at least 15 months. 
It is interesting to note that the observed prevalence of diabetes type 1 and 2 in the FIRE database 
with 4,832 of 136,132 patients was lower than epidemiologic experts would expect. However, it 
must be acknowledged that our study was not designed to assess the epidemiology of the disease 
but processes of care. So, we sought undisputed indicators of the disease that would not be 
subject of the quality indicator set at the same time. If we had also included all patients with at 
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least one HbA1c value over the 6.5% threshold, the observed prevalence of diabetes would have 
been closer to the expected prevalence.  
 
The general question, whether concentration on easily measurable clinical processes would be 
sufficient to describe quality of care comprehensively, cannot be answered by our results. 
However, the characteristics of our study population indicate, that future approaches of health 
politics towards quality measures need to take into account that patients with diabetes in Swiss 
primary care are of advanced age and have multiple chronic conditions. As Hunger et al. 
reported, diabetes combined with cardiovascular comorbidities has superadditive effects on 
HRQL (33). This evidence should promote the development of additional quality indicators that 
mirror the dealing with patients’ issues concerning HRQL. GPs can act as an important resource 
in patients’ social network and the influence of social support on HRQL of patients suffering 
from multiple chronic conditions has been showed (34), so the development of respective quality 
indicators could be considered. In particular, because a simple clinically focused QOF which fails 
to make allowance for age or multimorbidity involves the danger of overtreatment, especially 
when associated with a pay-for-performance reimbursement (35).  
In our study, we deliberately refrained from informing the participating practices about the 
assessment of quality indicators or from any incentives for participating. We aimed to document 
the current routine of medical documentation free from any incentives and set a landmark, 
assessing baseline data that will help to observe future trends in the quality of medical 
documentation. A recent cross-sectional survey among elderly patients with diabetes in Swiss 
primary care supports the hypothesis, that the rate of electronically documented processes of care 
could be lower than the rate of processes that are really conducted in daily practice (36). In this 
survey, over 90% of patients claimed to have received annual testing of HbA1c, blood pressure, 
lipids and body weight, indicating much higher rates than our observation based on EMR entries. 
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A lack of financial incentives has been identified to be an important barrier to structured work 
flows in diabetes care from the physicians’ point of view (37). Moreover, experience from the 
NHS QOF and similar incentive based disease management programs in other countries 
underline the influence of financial incentives on the quality of medical documentation. For 
instance, in Germany, the Saxon Diabetes Management Program that compromised, inter alia, 
incentives for data documentation by GPs, reported an increase of completed data to 91–98% 
(38). On the other hand, retrospective investigations in England have shown that an overall 
increase of the recorded quality of diabetes care had already existed in the pre-QOF period, just 
like in other countries and irrespective of the introduction of the pay-for-performance scheme in 
2004 (29; 39; 40). It is very likely that such trends will also appear in Switzerland when the 
fraction of GPs using EMR software rises. Against this backdrop, further research on the impact 
of different incentive programs will benefit from our baseline data.  
 
Conclusions 
Our study shows that the Swiss ambulatory health care system lacks important prerequisites for 
the successful implementation of a Quality and Outcomes Framework in diabetes care with or 
without associated pay-for-performance reimbursement system. Despite technical feasibility of a 
structured data export from EMRs to an evaluation institution, it was not possible to obtain data 
that reliably reflect the relevant working processes and outcome achievements of the participating 
GPs. A high amount of missing data made it impossible to evaluate the actual quality of care. 
Thus, there is no basis for a simple monitoring of quality of care nor for a reimbursement policy 
that rewards achievements in quality of care. 
22 
Djalali, et al. Gerontology 2014; DOI: 10.1159/000357370 
In a first step, Swiss EMR software products need to be adapted, so that the content of structured 
data is increased and the data capturing is eased. Standards for electronic medical documentation 
and EMR use need to be set.  
It should also be acknowledged that important dimensions of suffering from one or more chronic 
diseases are not reflected by a system focusing only on somatic aspects of a disease. It should be 
carefully considered how psychological and psychosocial demands of multimorbid patients can 
be addressed appropriately if such a system should be introduced. 
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Tables  
Table 1: Swiss quality and outcomes framework (SQOF) compared with NHS quality and outcomes framework (QOF)  
  
Indicator No. Swiss Quality and Outcomes Framework(SQOF) diabetes indicators 
Corresponding NHS Quality and Outcomes 
Framework (QOF) diabetes indicators 
Percentage of patients with 
diabetes from FIRE 
database in whom the 
indicator was fulfilled
N=1,781
Percentage of practices 
from FIRE database 
fullfilling indicator
N=46
Ind_01 Percentage of patients with diabetes whose 
notes record BMI in the previous 15 months 
since last consultation
Percentage of patients with diabetes whose 
notes record BMI in the previous 15 months 41.9 89.1
Ind_02 Percentage of patients with diabetes who have 
a record of HbA1c in the previous 15 months 
since last consultation
Percentage of patients with diabetes who have 
a record of HbA1c or equivalent in the previous 
15 months
75.6 95.7
Ind_03 Percentage of patients with diabetes in whom 
the last HbA1c is 7% or less in the previous 15 
months 
Percentage of patients with diabetes in whom 
the last HbA1c is 7% or less (or equivalent 
test/reference range depending on local 
laboratory) in the previous 15 months
41.4 89.1
Ind_04 Percentage of patients with diabetes in whom 
the last HbA1c is 8% or less in the previous 15 
months 
Percentage of patients with diabetes in whom 
the last HbA1c is 8% or less (or equivalent 
test/reference range depending on local 
laboratory) in the previous 15 months
62.1 95.7
Ind_05 Percentage of patients with diabetes in whom 
the last HbA1c is 9% or less in the previous 15 
months 
Percentage of patients with diabetes in whom 
the last HbA1c is 9% or less (or equivalent 
test/reference range depending on local 
laboratory) in the previous 15 months
70.3 95.7
Ind_06 Percentage of patients with diabetes who have 
a record of the blood pressure in the previous 
15 months since last consultation
Percentage of patients with diabetes who have 
a record of the blood pressure in the previous 
15 months
82.0 97.8
Ind_07 Percentage of patients with diabetes in whom 
the last blood pressure is 145/85 mmHg or 
less, measured within the the previous 15 
th
Percentage of patients with diabetes in whom 
the last blood pressure is 145/85 mmHg or 
less, measured within the the previous 15 
th
48.8 95.7
Ind_08 Percentage of patients with diabetes who have 
a record of total cholesterol in the previous 15 
months since last consultation
Percentage of patients with diabetes who have 
a record of total cholesterol in the previous 15 
months
37.2 71.7
Ind_09 Percentage of patients with diabetes whose last 
measured total cholesterol within the previous 
15 months is 5 mmol/l or less
Percentage of patients with diabetes whose last 
measured total cholesterol within the previous 
15 month is 5 mmol/l or less
22.0 67.4
Ind_10 Percentage of patients with diabetes who have 
had influenza immunization (ATC J07BB) in the 
preceding 1 September to 31 March
Percentage of patients with diabetes who have 
had influenza immunization in the preceding
1 September to 31 March
15.6 45.7
Ind_11 Percentage of patients with diabetes who have 
a record of serum creatinine testing in the 
previous 15 months since last consultation
Percentage of patients with diabetes who have 
a record of estimated glomerular filtration rate 
(eGFR) or serum creatinine testing in the 
previous 15 months
49.3 71.7
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Table 2: SQOF practice achievement points compared with NHS QOF practice achievement points 
 
Indicator No. Swiss Quality and Outcomes Framework (SQOF) Indicators 
Points available
(according to 
QOF 2009/10)
Payment stages 
in percent
(according to 
QOF 2009/10)
Percentage of SQOF 
practices achieving 
points >0 in relation 
to indicator
Percentage of NHS 
QOF practices 
achieving points >0 in 
relation to indicator
Ind_01 Percentage of patients with diabetes whose 
notes record BMI in the previous 15 months 
since last consultation
3 40-90% 43.5% 0.7 (23.3%) 99.9% 3.0 (100.0%)
Ind_02 Percentage of patients with diabetes who 
have a record of HbA1c in the previous 15 
months since last consultation
3 40-90% 89.1% 2.1 (70.0%) 99.9% 3.0 (100.0%)
Ind_03 Percentage of patients with diabetes in whom 
the last HbA1c is 7% or less in the previous 
15 months 
17 40-50% 54.3% 7.4 (43.5%) 99.8% 14.7 (86.5%)
Ind_04 Percentage of patients with diabetes in whom 
the last HbA1c is 8% or less in the previous 
15 months 
8 40-70% 80.4% 5.2 (65.0%) 99.7% 7.8 (97.5%)
Ind_05 Percentage of patients with diabetes in whom 
the last HbA1c is 9% or less in the previous 
15 months 
10 40-90% 87.0% 6.2 (62.0%) 99.8% 9.4 (94.0%)
Ind_06 Percentage of patients with diabetes who 
have a record of the blood pressure in the 
previous 15 months since last consultation
3 40-90% 93.5% 2.2 (73.3%) 99.9% 3.0 (100.0%)
Ind_07 Percentage of patients with diabetes in whom 
the last blood pressure is 145/85 mmHg or 
less, measured within the the previous 15 
months
18 40-60% 58.7% 7.6 (42.2%) 99.8% 17.9 (99.4%)
Ind_08 Percentage of patients with diabetes who 
have a record of total cholesterol in the 
previous 15 months since last consultation
3 40-90% 41.3% 0.7 (23.3%) 99.9% 3.0 (100.0%)
Ind_09 Percentage of patients with diabetes whose 
last measured total cholesterol within the 
previous 15 months is 5 mmol/l or less
6 40-70% 19.6% 0.6 (10.0%) 99.9% 6.0 (100.0%)
Ind_10 Percentage of patients with diabetes who 
have had influenza immunization (ATC 
J07BB) in the preceding 1 September to 31 
March
3 40-85% 15.2% 0.2 (6.7%) 99.9% 3.0 (100.0%)
Ind_11 Percentage of patients with diabetes who 
have a record of serum creatinine testing in 
the previous 15 months since last 
consultation
3 40-90% 58.7% 1.1 (36.7%) 99.9% 3.0 (100.0%)
Mean points 
achieved by SQOF 
practice 
(% of max. points 
available)
Mean points 
achieved by NHS 
QOF practice in 
2010/11 
(% of max. points 
available)
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